Product Code: ETC044950 | Publication Date: Aug 2023 | Updated Date: Feb 2025 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 | |
The Vietnam Chemotherapy Market is witnessing significant developments as the country`s healthcare system advances and awareness about cancer treatment options increases. Chemotherapy, as a crucial part of cancer therapy, is gaining prominence in Vietnam oncology sector. The rise in cancer incidence and prevalence, coupled with the growing aging population, has resulted in an increased demand for chemotherapy drugs and treatments. Moreover, advancements in medical research and technology have led to the availability of a wider range of chemotherapy drugs, offering more personalized treatment options for cancer patients. The government`s efforts to improve healthcare infrastructure and access to advanced cancer treatments are also supporting the market`s growth. Key players in the pharmaceutical industry are focusing on research and development to introduce novel chemotherapy drugs and improve existing treatments` efficacy and safety. With a comprehensive approach towards cancer care and increased patient awareness, the Vietnam Chemotherapy Market is expected to grow further and contribute significantly to better cancer management in the country.
The Vietnam Chemotherapy Market is influenced by various drivers. The rising prevalence of cancer in the country, particularly lung, breast, and liver cancers, has resulted in an increased demand for chemotherapy treatments. The growing aging population and lifestyle changes, including smoking and poor dietary habits, have contributed to the rising cancer incidence in Vietnam. The government`s efforts to improve healthcare infrastructure and accessibility to cancer treatments have also driven the market`s growth. Advancements in medical research and technology have led to the availability of a wide range of chemotherapy drugs, providing patients with more personalized treatment options. Moreover, increasing awareness about cancer and the importance of early detection and treatment have encouraged patients to seek medical help and opt for chemotherapy services. As the healthcare sector continues to evolve, the Vietnam Chemotherapy Market is poised for significant growth to meet the increasing cancer burden in the country.
The Vietnam Chemotherapy Market faces several challenges that impact its effective functioning. One of the significant challenges is the limited accessibility of advanced chemotherapy treatments and facilities, especially in rural areas. The majority of cancer treatment centers and specialized oncology services are concentrated in urban regions, making it challenging for patients in remote areas to access timely and comprehensive chemotherapy care. Moreover, the cost of chemotherapy can be prohibitive for many patients, particularly in low-income and economically disadvantaged populations. The expenses associated with chemotherapy drugs, treatment sessions, and supportive care can pose financial burdens on patients and their families, impacting treatment adherence and outcomes. Additionally, there is a shortage of skilled healthcare professionals specializing in oncology, including medical oncologists and oncology nurses. The lack of a well-trained workforce may lead to delays in diagnosis, treatment planning, and administration of chemotherapy, affecting patient outcomes. Furthermore, raising awareness about cancer prevention, early detection, and the importance of timely treatment remains a challenge. Public education and outreach programs are essential to encourage early diagnosis and timely initiation of chemotherapy, as many patients still present at later stages of cancer, reducing treatment efficacy.
The COVID-19 pandemic significantly affected the Vietnam Chemotherapy Market, especially in the initial phases. The outbreak strained healthcare resources, with hospitals and medical facilities redirecting their focus to manage COVID-19 cases. Non-urgent medical procedures, including elective chemotherapy treatments, were postponed, affecting cancer patients` access to necessary therapies. Additionally, movement restrictions and fear of exposure to the virus led to many patients avoiding hospital visits, impacting treatment adherence and cancer care outcomes. The supply chain disruptions also affected the availability of chemotherapy drugs and medical equipment, leading to temporary shortages. However, as the healthcare system adapted to the new normal and implemented safety protocols, chemotherapy services gradually resumed, and efforts were made to ensure cancer patients` continuous access to treatment.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Vietnam Chemotherapy Market Overview |
3.1 Vietnam Country Macro Economic Indicators |
3.2 Vietnam Chemotherapy Market Revenues & Volume, 2021 & 2031F |
3.3 Vietnam Chemotherapy Market - Industry Life Cycle |
3.4 Vietnam Chemotherapy Market - Porter's Five Forces |
3.5 Vietnam Chemotherapy Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Vietnam Chemotherapy Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.7 Vietnam Chemotherapy Market Revenues & Volume Share, By Route of Drug Administration, 2021 & 2031F |
3.8 Vietnam Chemotherapy Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
4 Vietnam Chemotherapy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Vietnam Chemotherapy Market Trends |
6 Vietnam Chemotherapy Market, By Types |
6.1 Vietnam Chemotherapy Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Vietnam Chemotherapy Market Revenues & Volume, By Drug Class, 2021-2031F |
6.1.3 Vietnam Chemotherapy Market Revenues & Volume, By Alkylating Agents, 2021-2031F |
6.1.4 Vietnam Chemotherapy Market Revenues & Volume, By Mitotic Inhibitors, 2021-2031F |
6.1.5 Vietnam Chemotherapy Market Revenues & Volume, By Antimetabolites, 2021-2031F |
6.1.6 Vietnam Chemotherapy Market Revenues & Volume, By Topoisomerase Inhibitors, 2021-2031F |
6.1.7 Vietnam Chemotherapy Market Revenues & Volume, By Antitumor Antibiotic, 2021-2031F |
6.2 Vietnam Chemotherapy Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 Vietnam Chemotherapy Market Revenues & Volume, By Lung Cancer, 2021-2031F |
6.2.3 Vietnam Chemotherapy Market Revenues & Volume, By Breast Cancer, 2021-2031F |
6.2.4 Vietnam Chemotherapy Market Revenues & Volume, By Colorectal Cancer, 2021-2031F |
6.2.5 Vietnam Chemotherapy Market Revenues & Volume, By Prostate Cancer, 2021-2031F |
6.2.6 Vietnam Chemotherapy Market Revenues & Volume, By Stomach Cancer, 2021-2031F |
6.2.7 Vietnam Chemotherapy Market Revenues & Volume, By Lymphoma, 2021-2031F |
6.2.8 Vietnam Chemotherapy Market Revenues & Volume, By Ovarian Cancer, 2021-2031F |
6.2.9 Vietnam Chemotherapy Market Revenues & Volume, By Ovarian Cancer, 2021-2031F |
6.3 Vietnam Chemotherapy Market, By Route of Drug Administration |
6.3.1 Overview and Analysis |
6.3.2 Vietnam Chemotherapy Market Revenues & Volume, By Intravenous, 2021-2031F |
6.3.3 Vietnam Chemotherapy Market Revenues & Volume, By Oral, 2021-2031F |
6.3.4 Vietnam Chemotherapy Market Revenues & Volume, By Subcutaneous, 2021-2031F |
6.3.5 Vietnam Chemotherapy Market Revenues & Volume, By Intra-Muscular, 2021-2031F |
6.3.6 Vietnam Chemotherapy Market Revenues & Volume, By Intravesicular, 2021-2031F |
6.3.7 Vietnam Chemotherapy Market Revenues & Volume, By Topical, 2021-2031F |
6.3.8 Vietnam Chemotherapy Market Revenues & Volume, By Intraventricular/Intrathecal, 2021-2031F |
6.3.9 Vietnam Chemotherapy Market Revenues & Volume, By Intraventricular/Intrathecal, 2021-2031F |
6.4 Vietnam Chemotherapy Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 Vietnam Chemotherapy Market Revenues & Volume, By Specialty Centers, 2021-2031F |
6.4.3 Vietnam Chemotherapy Market Revenues & Volume, By Hospitals & Clinics, 2021-2031F |
7 Vietnam Chemotherapy Market Import-Export Trade Statistics |
7.1 Vietnam Chemotherapy Market Export to Major Countries |
7.2 Vietnam Chemotherapy Market Imports from Major Countries |
8 Vietnam Chemotherapy Market Key Performance Indicators |
9 Vietnam Chemotherapy Market - Opportunity Assessment |
9.1 Vietnam Chemotherapy Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Vietnam Chemotherapy Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.3 Vietnam Chemotherapy Market Opportunity Assessment, By Route of Drug Administration, 2021 & 2031F |
9.4 Vietnam Chemotherapy Market Opportunity Assessment, By End-Users, 2021 & 2031F |
10 Vietnam Chemotherapy Market - Competitive Landscape |
10.1 Vietnam Chemotherapy Market Revenue Share, By Companies, 2024 |
10.2 Vietnam Chemotherapy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |